Psychologists rendering psychotherapeutic services to patients receiving ph
armacological treatment with the newer antidepressants are becoming more fa
miliar with their distinct therapeutic and side effect profiles. Increased
attention has recently been directed at the sexual dysfunction associated w
ith the use of these antidepressants. Among the newer agents, risk for the
emergence of sexual side effects is greater with the selective serotonin re
uptake inhibitors than with the atypical antidepressants. Psychologists who
are aware of treatment-related sexual dysfunction may be more effective in
collaborating with prescribing professionals to develop strategies that al
low patients to minimize or better tolerate these side effects.